NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > COVID-19 > Oxford study reveals public attitudes to vaccine roll-out programmes

Oxford study reveals public attitudes to vaccine roll-out programmes

23 February 2021 · Listed under COVID-19, Life-saving Vaccines

An international study led by University of Oxford health economists and political scientists has found that there is much greater consistency in public attitudes across a number of countries about who should be prioritised for COVID-19 vaccination than there is in national policies.

photo (c) John Cairns, University of Oxford

The study, published on the medRxiv pre-print server, could have important implications for vaccine prioritisation policies and roll-out strategies. The research was supported by the NIHR Oxford Biomedical Research Centre (BRC) and the COVID-19 Oxford Vaccine Trial.

The study surveyed 15,536 members of the public in 13 diverse countries to understand preferences and opinions regarding the allocation of a COVID-19 vaccine.

Unsurprisingly, those surveyed agreed that age, vulnerability and risk of transmission should be important factors for prioritising vaccination. It was notable, however, that they would also prioritise according to what might be deemed more economic factors, including low income groups and a wide range of non-health related key occupations, such as teachers and non-key workers who are unable to work from home.

So far, only a minority of countries have given priority to vaccinating groups of key workers, such as teachers.

“Although there is considerable variation in COVID-19 vaccine allocation policies in the countries we surveyed, there does seem to be a great deal of consistency across geographically, economically and culturally diverse countries with regard to the public’s preferences for prioritisation,” said Dr Laurence Roope, a senior researcher at the University of Oxford’s Health Economics Research Centre (HERC), and one of the authors of the study.

Professor Philip Clarke, Director of HERC, added: “We hope the results of our study help to inform the ongoing debate over how COVID-19 vaccination programmes should be implemented. They identify opportunities for policymakers, who have often struggled during the pandemic to balance the need to protect public health and the economy, while taking account of public opinion. Encouragingly and somewhat remarkably, the results on who should be prioritised are consistent across the political divide.”

Among other notable findings was that respondents consistently preferred government-only allocation of vaccines. However, a significant proportion, especially in low and middle income countries, said they would be willing to purchase them on the private market to receive the vaccine faster.

“This has possible implications for both coverage and affordability,” Professor Ray Duch, Director of the University of Oxford’s Centre for Experimental Social Sciences and a co-author of the paper, explained. “If COVID-19 vaccines are to be allocated privately, given the constraints on vaccine supply, there is a clear risk that countries will find it harder to acquire the necessary doses to carry out their ‘official’ vaccination campaigns.”

The survey also showed that mandating COVID-19 vaccination has considerable support in many countries, but public opinion is more polarised in counties like the US, the UK and France, with the latter being overwhelmingly opposed.

← Oxford study shows high level of readmissions and death after COVID-19 discharge
Oxford academics named NIHR Senior Investigators →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre